loadpatents
name:-0.025070905685425
name:-0.012789011001587
name:-0.0069961547851562
MAFFEI; Paola Patent Filings

MAFFEI; Paola

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAFFEI; Paola.The latest application filed is for "pharmaceutical compositions in the form of gel containing xyloglucan and alcohols for the controlled release of active ingredients".

Company Profile
7.13.24
  • MAFFEI; Paola - Bologna IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Compositions In The Form Of Gel Containing Xyloglucan And Alcohols For The Controlled Release Of Active Ingredients
App 20220241193 - Viscomi; Giuseppe Claudio ;   et al.
2022-08-04
Substantially Sodium Free Diclofenac Potassium Oral Solutions
App 20220054440 - REINER; Giorgio ;   et al.
2022-02-24
Oral compositions for the treatment of gastroesophageal reflux
Grant 11,241,452 - Maffei , et al. February 8, 2
2022-02-08
Substantially sodium free diclofenac potassium oral solutions
Grant 11,123,318 - Reiner , et al. September 21, 2
2021-09-21
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20210244714 - VISCOMI; Giuseppe Claudio ;   et al.
2021-08-12
Substantially Sodium Free Diclofenac Potassium Oral Solutions
App 20200093772 - Reiner; Giorgio ;   et al.
2020-03-26
Nsaid Administration And Related Compositions, Methods And Systems
App 20190388411 - VISCOMI; Giuseppe Claudio ;   et al.
2019-12-26
Oral Compositions For The Treatment Of Gastroesophageal Reflux
App 20190314402 - Maffei; Paola ;   et al.
2019-10-17
Solvated crystal form of rifaximin, production, compositions and uses thereof
Grant 10,428,086 - Viscomi , et al. October 1, 2
2019-10-01
Use of polyols to obtain stable polymorphous forms of rifaximin
Grant 10,280,177 - Maffei , et al.
2019-05-07
Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections
Grant 10,258,610 - Viscomi , et al.
2019-04-16
Solvated Crystal Form Of Rifaximin, Production, Compositions And Uses Thereof
App 20180354971 - VISCOMI; Giuseppe Claudio ;   et al.
2018-12-13
Solvated crystal form of rifaximin, production, compositions and uses thereof
Grant 9,938,298 - Viscomi , et al. April 10, 2
2018-04-10
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaxmin
App 20170101417 - MAFFEI; Paola ;   et al.
2017-04-13
New Solvated Crystal Form Of Rifaximin, Production, Compositions And Uses Thereof
App 20170088557 - VISCOMI; Giuseppe Claudio ;   et al.
2017-03-30
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20170071916 - VISCOMI; Giuseppe Claudio ;   et al.
2017-03-16
Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
Grant 9,498,442 - Viscomi , et al. November 22, 2
2016-11-22
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20150080421 - VISCOMI; Giuseppe Claudio ;   et al.
2015-03-19
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaxmin
App 20150072002 - MAFFEI; Paola ;   et al.
2015-03-12
Nsaid Administration And Related Compositions, Methods And Systems
App 20140308350 - VISCOMI; Giuseppe Claudio ;   et al.
2014-10-16
Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect
Grant 8,748,447 - Viscomi , et al. June 10, 2
2014-06-10
Use of polyols to obtain stable polymorphous forms of rifaximin
Grant 8,748,449 - Maffei , et al. June 10, 2
2014-06-10
Mucoadhesive Xyloglucan-containing Formulations Useful In Medical Devices And In Pharmaceutical Formulations
App 20130183325 - BOTTONI; Giuseppe ;   et al.
2013-07-18
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin
App 20130072676 - MAFFEI; Paola ;   et al.
2013-03-21
Pharmaceutical Compositions Comprising Rifaximin, Processes For Their Preparation And Their Use In The Treatment Of Vaginal Infections
App 20130028971 - VISCOMI; Giuseppe Claudio ;   et al.
2013-01-31
Rifaximin Powder, Process For Preparing The Same And Controlled Release Compositions Containing Said Rifaximin Useful For Obtaining A Long-lasting Effect
App 20130004576 - Viscomi; Giuseppe Claudio ;   et al.
2013-01-03
Pharmaceutical Formulations Containing Rifaximin, Processes For Their Obtainment And Method Of Treating Intestinal Disease
App 20120245192 - Viscomi; Giuseppe Claudio ;   et al.
2012-09-27
Compositions Comprising Nonsteroidal Anti - Inflammatory Drugs
App 20120238630 - Viscomi; Giuseppe Claudio ;   et al.
2012-09-20
Use of polyols to obtain stable polymorphous forms of rifaximin
Grant 8,217,054 - Maffei , et al. July 10, 2
2012-07-10
Mucoadhesive Xyloglucan-containing Formulations Useful In Medical Devices And In Pharmaceutical Fromulations
App 20120088726 - Bottoni; Giuseppe ;   et al.
2012-04-12
Use Of Polyols To Obtain Stable Polymorphous Forms Of Rifaximin
App 20100010028 - Maffei; Paola ;   et al.
2010-01-14
Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical fromulations
App 20090081133 - Bottoni; Giuseppe ;   et al.
2009-03-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed